Baseline characteristics of eyes with early residual fluid post loading phase of aflibercept therapy in neovascular AMD: PRECISE study report 3.
Shruti ChandraSarega GurudasIan PearceMartin McKibbinAjay KotagiriGeeta MenonBenjamin J L BurtonJames TalksAnna GrabowskaFaruque D GhanchiRichard GaleAndrea GianiNgai Victor ChongChing Ning Taffeta ChenLuke NicholsonSridevi ThottarathSwati ChandakSobha SivaprasadPublished in: Eye (London, England) (2023)
On average, 50% of eyes have ERF after aflibercept LP. Clinically relevant baseline determinants of ERF include CST ≥ 418 µ and presence of only SRF. These eyes may require further monthly treatment before extending treatment intervals.